Induction of pancreatic neoplasia in the KRAS / TP53 Oncopig
Disease Models & Mechanisms · 2023
DOI: 10.1242/dmm.049699 ↗Kurz gefasst
Fachartikel in der Zeitschrift Disease Models & Mechanisms, 2023. Verfasst von Pinaki Mondal und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of Nebraska Medical Center, Omaha, NE 68198, USA. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute, University of Nebraska Medical Center.
Abstract (Originalsprache)
The 5-year survival of pancreatic cancer (PC) remains low. Murine models may not adequately mimic human PC and can be too small for medical device development. A large-animal PC model could address these issues. We induced and characterized pancreatic tumors in Oncopigs (transgenic swine containing KRASG12D and TP53R167H). The oncopigs underwent injection of adenovirus expressing Cre recombinase (AdCre) into one of the main pancreatic ducts. Resultant tumors were characterized by histology, cytokine expression, exome sequencing and transcriptome analysis. Ten of 14 Oncopigs (71%) had gross tumor within 3 weeks. At necropsy, all of these subjects had gastric outlet obstruction secondary to pancreatic tumor and phlegmon. Oncopigs with injections without Cre recombinase and wild-type pigs with AdCre injection did not show notable effect. Exome and transcriptome analysis of the porcine pancreatic tumors revealed similarity to the molecular signatures and pathways of human PC. Although further optimization and validation of this porcine PC model would be beneficial, it is anticipated that this model will be useful for focused research and development of diagnostic and therapeutic technologies for PC. This article has an associated First Person interview with the joint first authors of the paper.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, University of Nebraska Medical Center, Omaha, NE 68198, USA.
- Department of Surgery and VA Research Service, Nebraska-Western Iowa Health Care System, Omaha, NE 68105, USA.
- Eppley Institute for Research in Cancer and Allied Diseases, Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE 68198, USA.
- Department of Pathology, University of Nebraska Medical Center, Omaha, NE 68198, USA.
- Department of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, NE 68198, USA.
ORCID-Profile: Mark A Carlson
Förderung
- NCI NIH HHS
- National Cancer Institute
- University of Nebraska Medical Center
- Fred and Pamela Buffett Cancer Center
- College of Medicine, University of Nebraska Medical Center
Zitieren
APA
Mondal, P., Patel, N. S., Bailey, K., Aravind, S., Cartwright, S. B., Hollingsworth, M. A., Lazenby, A. J., & Carlson, M. A. (2023). Induction of pancreatic neoplasia in the KRAS / TP53 Oncopig. Disease Models & Mechanisms. https://doi.org/10.1242/dmm.049699
Vancouver
Mondal P, Patel NS, Bailey K, Aravind S, Cartwright SB, Hollingsworth MA, et al. Induction of pancreatic neoplasia in the KRAS / TP53 Oncopig. Disease Models & Mechanisms. 2023. doi:10.1242/dmm.049699
BibTeX
@article{Mondal2023,
author = {Mondal, Pinaki and Patel, Neesha S and Bailey, Katie and Aravind, Shruthishree and Cartwright, Sara B and Hollingsworth, Michael A and Lazenby, Audrey J and Carlson, Mark A},
title = {Induction of pancreatic neoplasia in the KRAS / TP53 Oncopig},
journal = {Disease Models & Mechanisms},
year = {2023},
doi = {10.1242/dmm.049699}
}
EUVIMED